Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
Chris Degeling, Justin Denholm, Paul Mason, Ian Kerridge, Angus Dawson
Journal of Medical Ethics | BMJ PUBLISHING GROUP | Published : 2017
Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide, and the burdens of this disease continue to track prior disadvantage. In order to galvanise a coordinated global response, WHO has recently launched the End TB Campaign that aims to eliminate TB by 2050. Key to this is the introduction of population screening programmes in low-burden settings to identify and treat people who have latent TB infection (LTBI). The defining features of LTBI are: that it is not an active disease but confers an increased risk of disease; the socially disadvantaged are those most in danger and uncertainty persists as to who will be harmed or benefitted from screening-led prophylactic in..View full abstract
Awarded by NHMRC Centre for Research Excellence in TB Control
NHMRC Centre for Research Excellence in TB Control (CRE 1043225).